- Home
- Publications
- Publication Search
- Publication Details
Title
T Helper 17 Cells in Primary Sjögren’s Syndrome
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 6, Issue 7, Pages 65
Publisher
MDPI AG
Online
2017-07-05
DOI
10.3390/jcm6070065
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral administration of a novel RORγt antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17
- (2017) Mikiro Takaishi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- The effect of bodyweight on the efficacy and safety of ixekizumab: results from an integrated database of three randomised, controlled Phase 3 studies of patients with moderate-to-severe plaque psoriasis
- (2017) K. Reich et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)
- (2016) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis
- (2016) M. Tahara et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- IL-17 in Chronic Inflammation: From Discovery to Targeting
- (2016) Audrey Beringer et al. TRENDS IN MOLECULAR MEDICINE
- Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjögren’s syndrome
- (2016) Alexandria Voigt et al. Scientific Reports
- CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity
- (2015) Chao Wang et al. CELL
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Th17 cells in autoimmune diseases
- (2015) Lei Han et al. Frontiers of Medicine
- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
- (2014) Christopher Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
- Th17 cells play a critical role in the development of experimental Sjögren's syndrome
- (2014) Xiang Lin et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)
- (2014) A. Blauvelt et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren’s syndrome
- (2014) Yunyun Fei et al. CLINICAL RHEUMATOLOGY
- Advances in the understanding and treatment of systemic complications in Sjögrenʼs syndrome
- (2014) Pilar Brito-Zerón et al. CURRENT OPINION IN RHEUMATOLOGY
- The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: A critical review
- (2014) Takayuki Sumida et al. JOURNAL OF AUTOIMMUNITY
- Identification of IL-18 and Th17 Cells in Salivary Glands of Patients with Sjogren's Syndrome, and Amplification of IL-17-Mediated Secretion of Inflammatory Cytokines from Salivary Gland Cells by IL-18
- (2014) A. Sakai et al. JOURNAL OF IMMUNOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
- (2013) Chuan Wu et al. NATURE
- Advances in understanding the pathogenesis of primary Sjögren's syndrome
- (2013) Gaëtane Nocturne et al. Nature Reviews Rheumatology
- Th17 cells and IL-17 A—Focus on immunopathogenesis and immunotherapeutics
- (2013) Wim B. van den Berg et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry
- (2012) Jacques-Eric Gottenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
- (2012) K. Attridge et al. BLOOD
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- CD4+T Cells: Differentiation and Functions
- (2012) Rishi Vishal Luckheeram et al. Clinical & Developmental Immunology
- Induction and molecular signature of pathogenic TH17 cells
- (2012) Youjin Lee et al. NATURE IMMUNOLOGY
- Topical and systemic medications for the treatment of primary Sjögren's syndrome
- (2012) Manuel Ramos-Casals et al. Nature Reviews Rheumatology
- Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjögren's syndrome
- (2011) Francesco Ciccia et al. ANNALS OF THE RHEUMATIC DISEASES
- Follicular Helper CD4 T Cells (TFH)
- (2011) Shane Crotty Annual Review of Immunology
- Structural Basis of Digoxin That Antagonizes RORγt Receptor Activity and Suppresses Th17 Cell Differentiation and Interleukin (IL)-17 Production
- (2011) Saori Fujita-Sato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
- (2011) Jun R. Huh et al. NATURE
- Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands
- (2011) Kwi Kang et al. ARTHRITIS RESEARCH & THERAPY
- Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial
- (2010) J. M. Meijer et al. ARTHRITIS AND RHEUMATISM
- IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer
- (2010) Cuong Q Nguyen et al. LABORATORY INVESTIGATION
- Proinflammatory T helper type 17 cells are effective B-cell helpers
- (2010) M. Mitsdoerffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- The elusive identity of T follicular helper cells
- (2010) Di Yu et al. TRENDS IN IMMUNOLOGY
- Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjögren’s Syndrome Immunopathogenesis
- (2009) Gikas E. Katsifis et al. AMERICAN JOURNAL OF PATHOLOGY
- Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
- (2009) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
- (2009) R Westhovens et al. ANNALS OF THE RHEUMATIC DISEASES
- Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome
- (2009) P. Szodoray et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjögren's syndrome
- (2009) M. Sarigul et al. LUPUS
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice
- (2009) C. S. De Paiva et al. RHEUMATOLOGY
- Foxp3+ T-Regulatory Cells in Sjögren's Syndrome
- (2008) Maria I. Christodoulou et al. AMERICAN JOURNAL OF PATHOLOGY
- Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
- (2008) S Dass et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Sjögren's syndrome: A quintessential B cell-induced autoimmune disease
- (2007) Pierre Youinou JOINT BONE SPINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started